The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback